Randomized phase II trial of bevacizumab and temsirolimus in combination with vinorelbine (V) and cyclophosphamide (C) for first relapse/disease progression of rhabdomyosarcoma (RMS): A report from the Children’s Oncology Group (COG).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Southern California, Children's Hospital of Los Angeles, USC Norris Comprehensive Cancer Center, Saban Research Institute, University of Oklahoma Health Sciences Center, University of Nebraska Medical Center, East Carolina University, University of Florida Health, University of Florida, University of Florida Health Science Center, Duke Medical Center, Seattle Children's Hospital, University of Washington, Fred Hutch Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2243095616